A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

November 14, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

March 31, 2026

Conditions
Advanced CancerAdvanced Solid TumorLung Cancer, Nonsmall Cell
Interventions
DRUG

SAF-189s

20mg,40mg,80mg,120mg,160mg,210mg,once daily

Trial Locations (41)

100140

RECRUITING

Peking Union Medical College Hospital, Beijing

100192

RECRUITING

Beijing Cancer Hospital, Beijing

101149

RECRUITING

Beijing Chest Hospital,Capital Medical University, Beijing

110001

RECRUITING

The first affiliated hospital of China medical university, Shenyang

130021

RECRUITING

Jilin Cancer Hospital, Jilin

130031

RECRUITING

The First Hospital of Jilin University, Changchun

133000

RECRUITING

Yanbian University Affiliated Hospital, Yanji

150081

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

200030

RECRUITING

Shanghai Chest Hospital,Shanghai Jiaotong University, Shanghai

221006

RECRUITING

General Hospital of Xuzhou Mining Group, Xuzhou

225001

RECRUITING

Jiangsu Province Hospital, Nanjing

233004

RECRUITING

he First Affiliated Hospital of Bengbu Medical College, Bengbu

250013

RECRUITING

Jinan Central Hospital, Jinan

250031

RECRUITING

No. 960 Hospital of the Joint Service Support Force of Chinese People's Liberation Army, Jinan

250061

RECRUITING

Shandong Provincial Qianfoshan Hospital, Jinan

276000

RECRUITING

Linyi Cancer Hospital, Linyi

300052

RECRUITING

Tianjin Medical University General Hospital, Tianjin

300060

RECRUITING

Tianjin Medical University Cancer Hospital, Tianjin

310000

RECRUITING

Shulan (Hangzhou) Hospital, Hangzhou

310009

RECRUITING

The First Affiliated Hospital, Medical School of Zhejiang University, Hangzhou

310014

RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

310016

RECRUITING

SIR RUN RUN SHAW HOSPITAL Zhejiang University School of Medicine, Hangzhou

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

330006

RECRUITING

The second Affiliated Hospital of Nanchang University, Nanchang

350000

NOT_YET_RECRUITING

Tianjin Peoples Hospital, Tianjin

410006

RECRUITING

Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha

425006

RECRUITING

The Central Hospital of Yongzhou, Yongzhou

430022

RECRUITING

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

430079

RECRUITING

Hubei Cancer Hospital, Wuhan

450014

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

450052

RECRUITING

Zhengzhou Central Hospital, Zhengzhou

471003

RECRUITING

The First Affiliated Hospital of Henan University of Science and Technology, Zhengzhou

510080

RECRUITING

Guangdong Province People's General Hospital, Guangzhou

510515

RECRUITING

Nanfang Hospital, Southern Medical University, Guangzhou

518116

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen

522000

RECRUITING

Jieyang Peoples Hospital, Jieyang

610041

RECRUITING

West China Hospital,Sichuan University, Chengdu

641100

RECRUITING

The second peoples hospital of Neijiang, Neijiang

071000

RECRUITING

Affiliated Hospital of Hebei University, Baoding

050000

RECRUITING

The Fourth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

INDUSTRY